The UK’s Medicines and Healthcare products Regulatory Agency has released a comprehensive updated registry documenting all medical devices operating under exceptional use authorisations, marking a significant step toward greater transparency in emergency regulatory pathways. The public registry includes active exemptions alongside expired and cancelled authorisations, providing healthcare systems and procurement specialists with clear visibility into the regulatory status of critical medical technologies. This initiative reflects evolving standards for accountability in emergency authorisation processes, enabling informed decision-making during public health crises. By maintaining detailed documentation of device exemptions across multiple categories—from diagnostic equipment to therapeutic interventions—the MHRA ensures that healthcare providers can verify regulatory status before clinical implementation. The transparency framework demonstrates how regulatory bodies balance the urgent need for emergency device access with public accountability measures during health emergencies. Read the full article on GMJ Newsroom.
Was this article helpful?
